Quinine
Quinine is an antimalarial medicine used in selected cases of malaria, particularly when alternative treatments are unsuitable or according to regional treatment guidelines. It works by interfering with the malaria parasite’s ability to detoxify haemoglobin breakdown products, leading to parasite death. It is available in oral formulations and, in some settings, injectable formulations for hospital-based treatment of severe malaria; the appropriate route depends on local guidelines and product availability. Common side effects include nausea, headache, dizziness, and visual disturbances, while a characteristic reaction known as cinchonism may cause ringing in the ears and hearing changes. Serious risks include low blood sugar, abnormal heart rhythms, and blood disorders such as thrombocytopenia. Quinine should be used under medical supervision, with appropriate monitoring, and is not recommended for routine treatment of uncomplicated malaria where safer, more effective alternatives are available.
Quinine was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Quinine, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Quinine from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Quinine, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
